Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor by J. P. Pham, P. Star, S. Wong, D. L. Damian, R. P. M. Saw, M. J. Whitfeld, A. M. Menzies, A. M. Joshua, A. Smith

Get full text